Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Microsoft
MSFT
|
+$381M |
| 2 |
Tesla
TSLA
|
+$268M |
| 3 |
Apple
AAPL
|
+$205M |
| 4 |
GE HealthCare
GEHC
|
+$180M |
| 5 |
Exelon
EXC
|
+$123M |
Top Sells
| 1 |
Check Point Software Technologies
CHKP
|
+$187M |
| 2 |
GE Aerospace
GE
|
+$180M |
| 3 |
CyberArk
CYBR
|
+$129M |
| 4 |
Cloudflare
NET
|
+$106M |
| 5 |
BlackBerry
BB
|
+$92.9M |
Sector Composition
| 1 | Technology | 26.4% |
| 2 | Healthcare | 13.8% |
| 3 | Financials | 12.19% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Impinj
PI
$5.2B
| $2.78M | ﹤0.01% |
20,541
+10,809
| +111% | +$1.46M |
|
1727
RLX Technology
RLX
$3.18B
| $2.78M | ﹤0.01% |
959,348
-119,393
| -11% | -$346K |
|
1728
Fresh Del Monte Produce
FDP
$1.71B
| $2.77M | ﹤0.01% |
91,845
+1,442
| +2% | +$43.4K |
|
1729
Telefônica Brasil
VIV
$20B
| $2.76M | ﹤0.01% |
365,464
| – | – |
|
1730
CRISPR Therapeutics
CRSP
$5.12B
| $2.76M | ﹤0.01% |
61,094
+6,039
| +11% | +$273K |
|
1731
Intellia Therapeutics
NTLA
$1.23B
| $2.76M | ﹤0.01% |
74,116
+1,699
| +2% | +$63.3K |
|
1732
TechTarget
TTGT
$427M
| $2.76M | ﹤0.01% |
76,348
-885
| -1% | -$32K |
|
1733
Adtran
ADTN
$809M
| $2.75M | ﹤0.01% |
173,703
-2,007
| -1% | -$31.8K |
|
1734
GDS Holdings
GDS
$7.32B
| $2.75M | ﹤0.01% |
147,716
-5,909
| -4% | -$110K |
|
1735
Pathward Financial
CASH
$1.72B
| $2.75M | ﹤0.01% |
66,177
-3,235
| -5% | -$134K |
|
1736
Stellar Bancorp
STEL
$1.61B
| $2.73M | ﹤0.01% |
110,956
+4,046
| +4% | +$99.6K |
|
1737
Nabors Industries
NBR
$617M
| $2.73M | ﹤0.01% |
22,371
-815
| -4% | -$99.4K |
|
1738
Arcus Biosciences
RCUS
$1.23B
| $2.71M | ﹤0.01% |
148,840
-1,735
| -1% | -$31.6K |
|
1739
Astec Industries
ASTE
$1.06B
| $2.71M | ﹤0.01% |
65,812
-629
| -0.9% | -$25.9K |
|
1740
Adeia
ADEA
$1.71B
| $2.7M | ﹤0.01% |
305,188
-1,051
| -0.3% | -$9.31K |
|
|
NVRO
1741
DELISTED
NEVRO CORP.
NVRO
| $2.7M | ﹤0.01% |
74,679
+7,193
| +11% | +$260K |
|
1742
Amicus Therapeutics
FOLD
$2.46B
| $2.7M | ﹤0.01% |
243,132
-108,499
| -31% | -$1.2M |
|
1743
Methanex
MEOH
$3.04B
| $2.69M | ﹤0.01% |
57,918
-3,231
| -5% | -$150K |
|
1744
Howard Hughes
HHH
$4.84B
| $2.69M | ﹤0.01% |
35,282
+2,409
| +7% | +$184K |
|
1745
Stewart Information Services
STC
$2.09B
| $2.68M | ﹤0.01% |
66,509
-2,128
| -3% | -$85.9K |
|
1746
Sprout Social
SPT
$803M
| $2.67M | ﹤0.01% |
43,860
+2,762
| +7% | +$168K |
|
1747
Helix Energy Solutions
HLX
$914M
| $2.67M | ﹤0.01% |
344,939
-4,405
| -1% | -$34.1K |
|
1748
Protolabs
PRLB
$1.18B
| $2.67M | ﹤0.01% |
80,455
+2,511
| +3% | +$83.2K |
|
1749
Veeco
VECO
$1.52B
| $2.66M | ﹤0.01% |
125,807
-1,382
| -1% | -$29.2K |
|
|
CGAU
1750
Centerra Gold
CGAU
$1.88B
| $2.63M | ﹤0.01% |
408,212
-6,133
| -1% | -$39.6K |
|